Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: August 22, 2018
Context: The filing serves as a Regulation FD disclosure to announce upcoming investor and analyst presentations. The company is designated as an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural disclosure regarding investor communications rather than a financial results report.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing solely addresses the intent to use specific presentation materials for upcoming investor meetings.
Guidance, Outlook, and Risks
- Management Commentary: Executive officers intend to use the material filed as Exhibit 99.1 (Investor Presentation dated August 2018) for upcoming presentations.
- Legal Status of Information: The information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
- Risks and Contingencies: No specific risks or contingencies are detailed in this text.
Key Facts for Investor Verification
- Verify the content of Exhibit 99.1 (Investor Presentation dated August 2018) for actual financial data and strategic outlook, as the 8-K text only references it.
- Confirm the company's status as an emerging growth company and its election regarding accounting standard transition periods.
- Note that the information in this filing is not incorporated by reference into other SEC filings unless specifically cited.